December 19th, 2024 – Zug, Switzerland: As part of its ongoing commitment to Corporate Social Responsibility (CSR), RGCC International is proud to announce a donation of CHF 15,000 to the Universitäts-Kinderspital Zürich (University Children's Hospital Zurich), furthering the company's commitment to Corporate Social Responsibility (CSR). This donation will support a range of essential services, including medical treatments, research, the procurement of medical devices, and the expansion of hospital facilities to better serve children in need.

The Universitäts-Kinderspital Zürich is renowned for its advanced pediatric care and dedicated services, but for many families, medical expenses beyond what is covered by insurance can add significant strain during an already difficult time. This donation from RGCC International aims to alleviate some of this burden by providing financial support for medical treatments, devices, and other essential resources that will make a meaningful difference in the lives of children in need.

"At RGCC, we believe in making a positive impact on society and supporting those who need it the most," said Dr. Ioannis Papasotiriou, Director of RGCC. "We are honored to contribute to the important work of Universitäts-Kinderspital Zürich and to support the families who rely on its care. It is our hope that this donation will ease some of the challenges faced by these children and their loved ones."

RGCC International remains committed to its CSR initiatives, continuously seeking opportunities to support communities and contribute to causes that make a lasting difference.

About RGCC International:
RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalized medicine. Today, RGCC is a leading innovator in the field of oncology diagnostics. Using world-leading technology, equipment, and innovative techniques, our team of scientists has developed a range of liquid biopsies that help physicians track cancer progression and tailor treatment plans based on individual patient profiles.

For general inquiries, please contact: office@rgcc-international.com